http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-65699-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 2002-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b168345eb9b26e7ae5d3b6b9e4bbb2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c4a3de3f09e9be0b4cb71f092702693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c368a568a2862e188017da1c6459e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_892e9a9441db5782a0fd423e9292abf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e2b0256a55a3694a6225cb9671a291a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2a83df01a0fc6064662ad252a7309d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18415aa8c5b5fd3c54f2bccc8a160bb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2813a0a40dbfee7911ef62c22d8fcbd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6ba494503ea5f0233dea58c515746af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519f0d32c4a9acdfa65626e997f49b29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f155e1993df3d221eb7eb20ba8d2744e
publicationDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-65699-B1
titleOfInvention METHOD FOR SYNTHESIS OF A KNOWN TETRAZOLE DERIVATIVE
abstract The invention relates to a method for the synthesis of the losartan potassium salt of the formula, in particular the potassium salt of 2-n-butyl-4-chloro-1 [(2'- (tetrazol-5-yl) -1,1'-biphenyl) -4-yl) methyl] imidazole-5-methanol. The yield of the finished product is increased. The process is run with starting compound 2-n-butyl-4-chloro-1 [(2'- (2-triphenylmethyl-2H-tetrazol-5-yl) -1,1'-biphenyl-4-yl) -methyl ] -1H-imidazole-4-methanol of formula (N) which is reacted in an alcohol of formula (N) in which R is a straight chain C 1 -C 4 alkyl group having 0.1-1 equivalent of potassium hydroxide. The final product of formula I is isolated after crystallization of the solution, the solvent being replaced with aprotic or slightly proton.
priorityDate 2000-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9310106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9517396-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454025817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410135424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131737471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454393109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1745

Total number of triples: 53.